POINT Biopharma Global Inc.

POINT Biopharma Global Inc is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Investing News NetworkYour trusted source for investing success

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

13 Canadian Crypto ETFs (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Rare Earths Stocks: 9 Biggest Companies in 2024

Uranium Stocks: 5 Biggest Companies in 2024

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Top 4 Largest Lithium Reserves by Country (Updated 2024)

Radiopharm achieves Nasdaq listing of ADS

First Helium Confirms Plans for Sequential Drilling of Two Oil Targets - Proven Undeveloped Oil Location and Large Leduc Anomaly

HyProMag USA Feasibility Study Demonstrates Robust Economics and the Opportunity to Develop a Major New, Domestic Source of Recycled Rare Earths Magnets for the United States

New Murchison Gold Provides a Mineral Resource Update for the Crown Prince Deposit

Antimony Project Acquired in Australia's Premier Province

CHARBONE Hydrogen Announces a First Closing of its $1M Non-Brokered Private Placement

First Helium

Purpose Bitcoin ETF

Soma Gold Corp.

Black Swan Graphene

2024 Gold Outlook Report

2024 Uranium Outlook

2024 Lithium Market Outlook

2024 Graphite Outlook Report

POINT Biopharma Global Inc.

5 US Longevity and Anti-aging Stocks to Watch in 2024

Stem Cell Stocks: 10 Biggest NASDAQ Companies

Interactive Chart